Racheli Ofir
Chief Executive Officer bij Betalin Therapeutics Ltd.
Profiel
Racheli Ofir is currently the Co-Chief Executive and Chief Technology Officer at Betalin Therapeutics Ltd.
Prior to this, she worked at Pluri, Inc. as the Vice President of Data and Intellectual Property from 2007 to 2022.
She holds a doctorate degree from both Technion-Israel Institute of Technology and Israel Institute of Technology.
Actieve functies van Racheli Ofir
| Bedrijven | Functie | Begin |
|---|---|---|
Betalin Therapeutics Ltd.
 Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Betalin Therapeutics Ltd. develops micro-pancreas and cell technology. The company is based in Jerusalem, Israel. The CEOs are Racheli Ofir, Moti Friedman. The Israeli company was founded in 2015 by Shuki Hershcovich. | Chief Executive Officer | 01-12-2022 |
Eerdere bekende functies van Racheli Ofir
| Bedrijven | Functie | Einde |
|---|---|---|
| PLURI INC. | Chief Tech/Sci/R&D Officer | 01-05-2022 |
Opleiding van Racheli Ofir
| Technion-Israel Institute of Technology | Doctorate Degree |
| Israel Institute of Technology | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PLURI INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Betalin Therapeutics Ltd.
Betalin Therapeutics Ltd. Packaged SoftwareTechnology Services Betalin Therapeutics Ltd. develops micro-pancreas and cell technology. The company is based in Jerusalem, Israel. The CEOs are Racheli Ofir, Moti Friedman. The Israeli company was founded in 2015 by Shuki Hershcovich. | Technology Services |
